null - FindTrial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224060

Enrollment

130

Registered

2018-09-25

Start date

2018-12-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 259 Other agents for uro-genital and anal organ Dosage and Administration for Investigat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
efficacy	—

Secondary

Measure	Time frame
efficacy efficacy	—

Countries

Europe, Japan

Contacts

Public ContactMedical Information Center

Astellas Pharma Inc.

clinicaltrialregistration@astellas.com+81-120-189-371

Outcome results